![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, February 27, 2020 4:09:41 PM
I made the decision that holding is worthwhile, I'm not worried about the day to day weakness, especially when coronavirus is killing the market. Am I adding to my position, if I had access funds I'd consider it, but not yet. What I do believe is that sometime later this year the company will finally give us another comprehensive update, then we can truly evaluate what we believe the potential is.
Right now, all we know is the skin cream will be further tested, and we believe that further testing of the sublingual tablet is anticipated as well. I believe before substantial funds are put out on the sublingual tablet, they need to know that they've still got a shot at patent approval.
I cannot tell you this stock will go to a dime, a dollar, or ten dollars, but I certainly believe it has that potential and more. Just the cream alone if approved as a drug by our FDA and other International regulators could potentially be a blockbuster drug. Even if OWCP partners the drug and only sees 10% of sales, what would $100 million in earnings do for the company. With the current shares outstanding, that would equate to about $.35 a share, with a P/E of 10, that's $3.50 if the P/E's 30, it's over $10. It could certainly be worth more than that, especially if additional patents come through, and of course if it's found effective against many skin disease, not just psoriasis, it could be a blockbuster many times over.
Gary
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM